SCHEMBL13367361

SCHEMBL13367361

CN(c1ccc(-c2ccc3ccccc3c2)cc1)c1ccc2ccccc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.52
ESR2 Q92731 3/20 0.52
ALOX5 P09917 1/20 0.46
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
HSD17B1 P14061 1/20 0.44
HSD17B2 P37059 1/20 0.44
LPL P06858 1/20 0.44
LIPG Q9Y5X9 1/20 0.44
GSTP1 P09211 1/20 0.42
HTR1D P28221 1/20 0.42
CYP17A1 P05093 1/20 0.42
CYP19A1 P11511 1/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
NPSR1 Q6W5P4 2/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14506081 0.94 ESR1 (0.46) ESR1ESR2ALOX5CA1CA2
SCHEMBL13826719 0.92 ESR1 (0.42) ESR1ESR2ALOX5HSD17B1HSD17B2
SCHEMBL22764497 0.92 CHKA (0.44) ESR1ESR2ALOX5GSTP1NPSR1
SCHEMBL12048712 0.92 ESR1 (0.42) ESR1ESR2ALOX5HSD17B1HSD17B2
SCHEMBL13367672 0.92 ESR1 (0.52) ESR1ESR2ALOX5CA1CA2
SCHEMBL19844105 0.92 ESR1 (0.52) ESR1ESR2ALOX5CA1CA2
SCHEMBL13177300 0.89 HTT (0.54) ESR1ESR2NPSR1HTTL3MBTL1
SCHEMBL13367561 0.89 ALDH1A1 (0.50) ESR1ESR2ALOX5CA1CA2
SCHEMBL12048441 0.89 ESR1 (0.40) ESR1ESR2ALOX5CA1CA2
SCHEMBL14506032 0.88 ESR1 (0.44) ESR1ESR2ALOX5CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 ESR1 221/4885ESR2 94/4885ALOX5 288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.